EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Haemodynamic phenotypes of pulmonary hypertension associated with left heart disease: a moving target

Christian Gerges iD, David Montani iD, Marc Humbert iD, Irene M Lang

European Respiratory Journal · 2024

DOI: 10.1183/13993003.02280-2023 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Respiratory Journal, 2024. Verfasst von Christian Gerges und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Heart Diseases, Heart Failure. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Respiratory Society, AOP Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Left heart disease (LHD) is the most common cause of pulmonary hypertension (PH) worldwide [1]. PH-LHD results from the upstream transmission of elevated left atrial pressure (LAP) and is associated with global pulmonary vascular remodeling of various degrees involving mainly pulmonary veins, but also capillaries and pulmonary arteries [2–4]. Morphological changes of the pulmonary vasculature in PH-LHD have been well described since the 1950s in patients with severe mitral stenosis. While pulmonary vascular remodeling was generally mild in the majority of cases, severe pulmonary vascular disease was observed in 13–28% of patients [3, 5]. Recent histological studies in PH-LHD cohorts confirm that pre-capillary pulmonary vascular remodeling, which shares similarities with pulmonary arterial hypertension (without plexiform lesions), is rare occurring in approximately ∼15% of cases [2, 4]. In these cases, the increase in mean pulmonary artery pressure (mPAP) may be out-of-proportion to LAP exceeding the 1:1 ratio as predicted by the PVR equation [6]. Footnotes This manuscript has recently been accepted for publication in the European Respiratory Journal . It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article. Conflict of Interest: Jonathan Grigg reports lecture honoraria from GSK; outside the submitted work. Conflict of Interest: Dr Gerges has received compensation for scientific symposia from AstraZeneca, AOP-Health, Cordis, Janssen and MSD, speaker fees from AOP-Health, AstraZeneca, Janssen and Ferrer, and an educational grant from AOP-Health. Conflict of Interest: Dr Montani has received speaker fees from Bayer, Janssen and MSD, consultancy fees from Acceleron, Janssen and MSD, and research grants from Acceleron, Janssen and MSD. Conflict of Interest: Dr Humbert has received speaker fees from Janssen and MSD, consultancy fees from Acceleron, Aerovate, Altavant, AOP-Health, Bayer, Chiesi, Ferrer, Janssen, MSD, MorphogenIX, Shou Ti, Tiakis and United Therapuetics, research grants from Acceleron, AOP-Health, Janssen, MSD and Shou Ti, and has served as an advisory board member for Acceleron, Altavant, Janssen, MSD and United Therapeutics. Conflict of Interest: Dr Lang has relationships with drug companies including AOP-Health, Actelion-Janssen, MSD, United Therapeutics, Medtronic, and Neutrolis. In addition to being investigator in trials involving these companies, relationships include consultancy service, research grants, and membership of scientific advisory boards.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryHeart DiseasesHeart FailureHumansHemodynamicsHeartPhenotype

Autor:innen und Institutionen

  • Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
  • Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Service de Pneumologie et Soins Intensifs Respiratoires, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • INSERM UMR_S 999, Le Kremlin-Bicêtre, France.

ORCID-Profile: Christian Gerges, David Montani, Marc Humbert

Förderung

  • European Respiratory Society
  • AOP Health

Zitieren

APA

Gerges, C., Montani, D., Humbert, M., & Lang, I. M. (2024). Haemodynamic phenotypes of pulmonary hypertension associated with left heart disease: a moving target. European Respiratory Journal. https://doi.org/10.1183/13993003.02280-2023

Vancouver

Gerges C, Montani D, Humbert M, Lang IM. Haemodynamic phenotypes of pulmonary hypertension associated with left heart disease: a moving target. European Respiratory Journal. 2024. doi:10.1183/13993003.02280-2023

BibTeX
@article{Gerges2024,
  author = {Gerges, Christian and Montani, David and Humbert, Marc and Lang, Irene M},
  title = {Haemodynamic phenotypes of pulmonary hypertension associated with left heart disease: a moving target},
  journal = {European Respiratory Journal},
  year = {2024},
  doi = {10.1183/13993003.02280-2023}
}
Kostenlos starten →